WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
OverviewZen ScorePriceValuationFinancialsForecastEarnings & RevenueDividends
OwnershipTechnicals
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
INCY
INCYTE CORP
$12.98BN/A0.00%N/AN/AN/AN/A
CORT
CORCEPT THERAPEUTICS INC
$3.14BN/A0.00%N/AN/AN/AN/A
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$1.67BN/A0.00%N/AN/AN/AN/A
PBYI
PUMA BIOTECHNOLOGY INC
$185.72MN/A0.00%N/AN/AN/AN/A
HALO
HALOZYME THERAPEUTICS INC
$5.64BN/A0.00%N/AN/AN/AN/A
UTHR
UNITED THERAPEUTICS CORP
$12.20BN/A0.00%N/AN/AN/AN/A
BMRN
BIOMARIN PHARMACEUTICAL INC
$14.25BN/A0.00%N/AN/AN/AN/A
EXEL
EXELIXIS INC
$6.32BN/A0.00%N/AN/AN/AN/A
GMAB
GENMAB A
$18.65BN/A0.00%N/AN/AN/AN/A
ROIV
ROIVANT SCIENCES LTD
$7.65BN/A0.00%N/AN/AN/AN/A
CPRX
CATALYST PHARMACEUTICALS INC
$1.91BN/A0.00%N/AN/AN/AN/A
TGTX
TG THERAPEUTICS INC
$2.52BN/A0.00%N/AN/AN/AN/A
REGN
REGENERON PHARMACEUTICALS INC
$108.00BN/A0.00%N/AN/AN/AN/A
RPRX
ROYALTY PHARMA PLC
$16.38B1.46%33.50%$0.2000$0.4031%0
PTGX
PROTAGONIST THERAPEUTICS INC
$1.65BN/A0.00%N/AN/AN/AN/A
FENC
FENNEC PHARMACEUTICALS INC
$185.24MN/A0.00%N/AN/AN/AN/A
MDXG
MIMEDX GROUP INC
$1.06BN/A0.00%N/AN/AN/AN/A
LPCN
LIPOCINE INC
$37.01MN/A0.00%N/AN/AN/AN/A
MEIP
MEI PHARMA INC
$19.06M0.00%44.60%N/A$0.00N/AN/A
VRTX
VERTEX PHARMACEUTICALS INC
$117.50BN/A0.00%N/AN/AN/AN/A
LGND
LIGAND PHARMACEUTICALS INC
$1.53BN/A0.00%N/AN/AN/AN/A
SRPT
SAREPTA THERAPEUTICS INC
$12.27BN/A0.00%N/AN/AN/AN/A
AVRO
AVROBIO INC
$66.44MN/A0.00%N/AN/AN/AN/A
ORMP
ORAMED PHARMACEUTICALS INC
$88.57MN/A0.00%N/AN/AN/AN/A
BNOX
BIONOMICS LIMITED
$9.70MN/A0.00%N/AN/AN/AN/A
SPRO
SPERO THERAPEUTICS INC
$76.66MN/A0.00%N/AN/AN/AN/A
KNSA
KINIKSA PHARMACEUTICALS LTD
$1.35BN/A0.00%N/AN/AN/AN/A
CRSP
CRISPR THERAPEUTICS AG
$4.56BN/A0.00%N/AN/AN/AN/A
TECH
BIO-TECHNE CORP
$12.16B0.41%25.20%$0.0800$0.326%1
JAZZ
JAZZ PHARMACEUTICALS PLC
$6.63BN/A0.00%N/AN/AN/AN/A
OCUP
OCUPHIRE PHARMA INC
$43.55MN/A0.00%N/AN/AN/AN/A
ADAG
ADAGENE INC
$123.53MN/A0.00%N/AN/AN/AN/A
PLX
PROTALIX BIOTHERAPEUTICS INC
$82.85MN/A0.00%N/AN/AN/AN/A
NVO
NOVO NORDISK A S
$610.11B1.01%47.80%$0.9299$1.3720%8
TRDA
ENTRADA THERAPEUTICS INC
$522.25MN/A0.00%N/AN/AN/AN/A
VTGN
VISTAGEN THERAPEUTICS INC
$104.32MN/A0.00%N/AN/AN/AN/A
OCUL
OCULAR THERAPEUTIX INC
$882.87MN/A0.00%N/AN/AN/AN/A
MNKD
MANNKIND CORP
$1.27BN/A0.00%N/AN/AN/AN/A
PRTA
PROTHENA CORP PUBLIC LTD CO
$1.12BN/A0.00%N/AN/AN/AN/A
VYNE
VYNE THERAPEUTICS INC
$36.90MN/A0.00%N/AN/AN/AN/A
QSI
QUANTUM-SI INC
$215.56MN/A0.00%N/AN/AN/AN/A
ZLAB
ZAI LAB LTD
$1.76BN/A0.00%N/AN/AN/AN/A
JANX
JANUX THERAPEUTICS INC
$2.77BN/A0.00%N/AN/AN/AN/A
MIRM
MIRUM PHARMACEUTICALS INC
$1.13BN/A0.00%N/AN/AN/AN/A
FULC
FULCRUM THERAPEUTICS INC
$487.91MN/A0.00%N/AN/AN/AN/A
SPRB
SPRUCE BIOSCIENCES INC
$30.50MN/A0.00%N/AN/AN/AN/A
GNFT
GENFIT SA
$258.15MN/A0.00%N/AN/AN/AN/A
INM
INMED PHARMACEUTICALS INC
$2.47MN/A0.00%N/AN/AN/AN/A
PRAX
PRAXIS PRECISION MEDICINES INC
$811.94MN/A0.00%N/AN/AN/AN/A
KZR
KEZAR LIFE SCIENCES INC
$50.52MN/A0.00%N/AN/AN/AN/A
ACIU
AC IMMUNE SA
$461.27MN/A0.00%N/AN/AN/AN/A
ANIX
ANIXA BIOSCIENCES INC
$77.52MN/A0.00%N/AN/AN/AN/A
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$64.20MN/A0.00%N/AN/AN/AN/A
ZYME
ZYMEWORKS INC
$599.58MN/A0.00%N/AN/AN/AN/A
AGIO
AGIOS PHARMACEUTICALS INC
$2.06BN/A0.00%N/AN/AN/AN/A
VRDN
VIRIDIAN THERAPEUTICS INC
$762.68MN/A0.00%N/AN/AN/AN/A
VNDA
VANDA PHARMACEUTICALS INC
$297.39MN/A0.00%N/AN/AN/AN/A
XBIO
XENETIC BIOSCIENCES INC
$6.01MN/A0.00%N/AN/AN/AN/A
KRYS
KRYSTAL BIOTECH INC
$4.57BN/A0.00%N/AN/AN/AN/A
RNA
AVIDITY BIOSCIENCES INC
$2.57BN/A0.00%N/AN/AN/AN/A
ARGX
ARGENX SE
$21.96BN/A0.00%N/AN/AN/AN/A
DNTH
DIANTHUS THERAPEUTICS INC
$634.24MN/A0.00%N/AN/AN/AN/A
KPRX
KIORA PHARMACEUTICALS INC
$12.94MN/A0.00%N/AN/AN/AN/A
PHAR
PHARMING GROUP NV
$614.03MN/A0.00%N/AN/AN/AN/A
CUE
CUE BIOPHARMA INC
$79.29MN/A0.00%N/AN/AN/AN/A
TARS
TARSUS PHARMACEUTICALS INC
$1.25BN/A0.00%N/AN/AN/AN/A
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$967.79MN/A0.00%N/AN/AN/AN/A
TFFP
TFF PHARMACEUTICALS INC
$6.38MN/A0.00%N/AN/AN/AN/A
DBVT
DBV TECHNOLOGIES SA
$108.01MN/A0.00%N/AN/AN/AN/A
AUTL
AUTOLUS THERAPEUTICS PLC
$1.11BN/A0.00%N/AN/AN/AN/A
BRNS
BARINTHUS BIOTHERAPEUTICS PLC
$74.55MN/A0.00%N/AN/AN/AN/A
GLYC
GLYCOMIMETICS INC
$17.47MN/A0.00%N/AN/AN/AN/A
BGNE
BEIGENE LTD
$15.58BN/A0.00%N/AN/AN/AN/A
FATE
FATE THERAPEUTICS INC
$418.90MN/A0.00%N/AN/AN/AN/A
BNTX
BIONTECH SE
$23.92BN/A0.00%$2.1110N/AN/A0
ALT
ALTIMMUNE INC
$532.48MN/A0.00%N/AN/AN/AN/A
XCUR
EXICURE INC
$3.84MN/A0.00%N/AN/AN/AN/A
IDYA
IDEAYA BIOSCIENCES INC
$2.77BN/A0.00%N/AN/AN/AN/A
CALT
CALLIDITAS THERAPEUTICS AB
$1.19BN/A0.00%N/AN/AN/AN/A
LEGN
LEGEND BIOTECH CORP
$7.28BN/A0.00%N/AN/AN/AN/A
CTMX
CYTOMX THERAPEUTICS INC
$132.46MN/A0.00%N/AN/AN/AN/A
LXRX
LEXICON PHARMACEUTICALS INC
$418.60MN/A0.00%N/AN/AN/AN/A
SAGE
SAGE THERAPEUTICS INC
$668.62MN/A0.00%N/AN/AN/AN/A
SEER
SEER INC
$116.89MN/A0.00%N/AN/AN/AN/A
CRNX
CRINETICS PHARMACEUTICALS INC
$3.50BN/A0.00%N/AN/AN/AN/A
CMRX
CHIMERIX INC
$86.67MN/A0.00%N/AN/AN/AN/A
ABSI
ABSCI CORP
$476.08MN/A0.00%N/AN/AN/AN/A
XOMA
XOMA CORP
$300.16MN/A0.00%N/AN/AN/AN/A
YMAB
Y-MABS THERAPEUTICS INC
$530.98MN/A0.00%N/AN/AN/AN/A
ACAD
ACADIA PHARMACEUTICALS INC
$2.49BN/A0.00%N/AN/AN/AN/A
ZNTL
ZENTALIS PHARMACEUTICALS INC
$843.64MN/A0.00%N/AN/AN/AN/A
VERV
VERVE THERAPEUTICS INC
$435.78MN/A0.00%N/AN/AN/AN/A
BLUE
BLUEBIRD BIO INC
$98.73MN/A0.00%N/AN/AN/AN/A
CHRS
COHERUS BIOSCIENCES INC
$208.80MN/A0.00%N/AN/AN/AN/A
MESO
MESOBLAST LTD
$755.01MN/A0.00%N/AN/AN/AN/A
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
$1.05BN/A0.00%N/AN/AN/AN/A
AUPH
AURINIA PHARMACEUTICALS INC
$775.16MN/A0.00%N/AN/AN/AN/A
GLMD
GALMED PHARMACEUTICALS LTD
$2.22MN/A0.00%N/AN/AN/AN/A
APRE
APREA THERAPEUTICS INC
$25.90MN/A0.00%N/AN/AN/AN/A
MRKR
MARKER THERAPEUTICS INC
$34.52MN/A0.00%N/AN/AN/AN/A
1234567

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 70, which is 48 points higher than the biotech industry average of 22. It passed 22 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -6.11% over the past year, overperforming other biotech stocks by 14 percentage points.

Incyte has an average 1 year price target of $74.15, an upside of 28.32% from Incyte's current stock price of $57.79.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the second best biotech stock with a Zen Score of 67, which is 45 points higher than the biotech industry average of 22. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 28.44% over the past year, overperforming other biotech stocks by 49 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 34.79% from Corcept Therapeutics's current stock price of $30.17.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third best biotech stock with a Zen Score of 66, which is 44 points higher than the biotech industry average of 22. It passed 22 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -14.98% over the past year, overperforming other biotech stocks by 5 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $39.80, an upside of 35.37% from Harmony Biosciences Holdings's current stock price of $29.40.

Harmony Biosciences Holdings stock has a consensus Hold recommendation according to Wall Street analysts. Of the 5 analysts covering Harmony Biosciences Holdings, 40% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 20% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 2 biotech stocks that have issued dividends in the past year, the 2 biotech stocks with the highest dividend yields are:

1. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.01%, which is the same as the biotech industry average of 0.72%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

2. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.41%, which is the same as the biotech industry average of 0.72%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 25.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.64% in the last day, and up 0.13% over the last week. Ac Immune Sa was the among the top gainers in the biotechnology industry, gaining 17.13% yesterday.

AC Immune shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and $8 price target.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Incyte's stock has dropped -6.11% in the past year. It has overperformed other stocks in the biotech industry by 14 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -16.28% in the past year. It has overperformed other stocks in the biotech industry by 4 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.98% in the past year. It has overperformed other stocks in the biotech industry by 5 percentage points.

Are biotech stocks a good buy now?

52.12% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 82.36% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -14.17x.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.